| Sep 22 2026 |
China Newsletter | Q2 2026 Issue No. 68 |
Greenberg Traurig, LLP |
| Sep 22 2026 |
SEC Proposes to Modernize the Proxy Solicitation Process |
Hunton Andrews Kurth |
| Sep 22 2026 |
More Than Exceptions: Disclosure Schedules as a Value-Protection Tool in Transactions |
Darrow Everett LLP |
| Sep 21 2026 |
SEC Issues ‘Innovation Exemption’ for On-Chain Trading of Tokenized NMS Stocks |
Greenberg Traurig, LLP |
| Sep 21 2026 |
An Overview of the US PE Funds and the M&A Market and the Continued Investment Growth in Israel |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 18 2026 |
SEC Grants Review of Nasdaq’s Proposed $5 Million Minimum Market Value of Listed Securities Rule |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 18 2026 |
Mexico Proposes New Foreign Investment Review Regime on National Security Grounds |
Greenberg Traurig, LLP |
| Sep 18 2026 |
SEC Proposes to Rescind Rule 14a-8 |
Hunton Andrews Kurth |
| Sep 16 2026 |
United States: SEC Proposes Modernization Overhaul of Transfer Agent Rules |
K&L Gates LLP |
| Sep 16 2026 |
The Growth Docket |
Foley & Lardner LLP |
| Sep 16 2026 |
SEC and FDA Partner on Legal Compliance for Food and Drug Industries |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Sep 16 2026 |
Is the Gig Up? Equity Compensation for Platform Workers, Influencers, and Brand Ambassadors |
Foley & Lardner LLP |
| Sep 16 2026 |
Senate Fails to Advance CLARITY Act |
Hunton Andrews Kurth |
| Sep 15 2026 |
A New Regulatory Framework for Transfer Agents: An Analysis of the SEC’s Modernization Proposal and Industry Implications |
Greenberg Traurig, LLP |
| Sep 15 2026 |
SEC Proposes End to Pay-to-Play Rule — But Compliance is Not Over |
Stark & Stark |
| Sep 11 2026 |
SEC and FDA Sign Memorandum of Understanding Formalizing Cross-Agency Information Sharing |
Barnes & Thornburg LLP |
| Sep 10 2026 |
FinCEN’s $13 Billion Scam Center Alert: What Banks Need to Know About the Fastest-Growing Financial Crime Threat |
Bradley Arant Boult Cummings LLP |
| Sep 9 2026 |
SEC Proposes Sweeping Modernization of Transfer Agent Rules |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 9 2026 |
SEC and CFTC Further Extend Compliance Date for 2024 Form PF Amendments |
Proskauer Rose LLP |
| Sep 9 2026 |
FDA and SEC Enter MOU to Establish Information Sharing Framework |
Keller and Heckman LLP |
| Sep 8 2026 |
SEC Staff Issues New CFIs Concerning Schedule 13G Eligibility |
Barnes & Thornburg LLP |
| Sep 8 2026 |
Enhanced FDA-SEC Collaboration: How Life Sciences Companies Think About Disclosure, Insider Trading, and Prediction Markets |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 8 2026 |
When the Structure Isn’t Right: LLCs, Check-the-Box, and the §1045 Rollover (Part IV of IV) |
Strassburger McKenna Gutnick & Gefsky |
| Sep 4 2026 |
United States - Away With Pay to Play? |
K&L Gates LLP |
| Sep 3 2026 |
Housing Finance — When Helping a Deal Can Cross a Regulatory Line |
Miller Canfield |
| Sep 3 2026 |
Fair Credit Reporting Act Disputes: When Furnisher Investigations Fall Short |
Nelson Mullins |
| Sep 3 2026 |
A Preview of SEC Fall Rulemaking for Public Companies |
Hunton Andrews Kurth |
| Sep 1 2026 |
Qualified Small Business Stock, Recapitalizations and Code Section 305 |
Darrow Everett LLP |
| Aug 31 2026 |
Building an AI Governance Program That Satisfies Both DOJ and SEC Compliance Expectations |
Bradley Arant Boult Cummings LLP |
| Aug 27 2026 |
SEC Staff Grants No-Action Relief for Digital Asset Custody |
Greenberg Traurig, LLP |
| Aug 27 2026 |
Does the Stock Qualify — and Will It Still? (Part III of IV) |
Strassburger McKenna Gutnick & Gefsky |
| Aug 26 2026 |
Investment Management Client Alert August 2026 |
K&L Gates LLP |
| Aug 26 2026 |
Does the Business Qualify? The Five Tests Every QSBS Issuer Must Satisfy (Part II of IV) |
Strassburger McKenna Gutnick & Gefsky |
| Aug 25 2026 |
Colorado Changes Notice Filing Requirements for SEC-Registered Investment Advisers |
Stark & Stark |
| Aug 25 2026 |
E-2 Visa for South Korean Investors |
Colombo & Hurd |
